{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T14:05:51Z","timestamp":1753884351644,"version":"3.41.2"},"reference-count":73,"publisher":"The Ewha Medical Journal, Ewha Womans University College of Medicine","issue":"s1","license":[{"start":{"date-parts":[[2023,12,31]],"date-time":"2023-12-31T00:00:00Z","timestamp":1703980800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["www.e-emj.org"],"crossmark-restriction":true},"short-container-title":["Ewha Med J"],"DOI":"10.12771\/emj.2023.e32","type":"journal-article","created":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T05:47:44Z","timestamp":1705297664000},"update-policy":"https:\/\/doi.org\/10.12771\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Management of Hyperphagia and Obesity in Prader\u2013Willi Syndrome"],"prefix":"10.12771","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9190-5988","authenticated-orcid":false,"given":"JiHoon","family":"Hwang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2913-059X","authenticated-orcid":false,"given":"Sung Yoon","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4998","published-online":{"date-parts":[[2023,12,31]]},"reference":[{"issue":"1","key":"key2.024011506525e+13_B1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/gim.0b013e31822bead0","article-title":"Prader-Willi syndrome","volume":"14","author":"Cassidy","year":"2012","journal-title":"Genet Med"},{"issue":"1","key":"key2.024011506525e+13_B2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/ejhg.2008.165","article-title":"Prader\u2013Willi syndrome","volume":"17","author":"Cassidy","year":"2009","journal-title":"Eur J Hum Genet"},{"issue":"4","key":"key2.024011506525e+13_B3","doi-asserted-by":"crossref","first-page":"780","DOI":"10.3945\/ajcn.115.112581","article-title":"Comparison of low- and high-carbohydrate diets for type 2 diabetes management: a randomized trial","volume":"102","author":"Tay","year":"2015","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"key2.024011506525e+13_B4","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1002\/ajmg.a.33951","article-title":"Nutritional phases in Prader\u2013Willi syndrome","volume":"155","author":"Miller","year":"2011","journal-title":"Am J Med Genet A"},{"issue":"1","key":"key2.024011506525e+13_B5","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/ajmg.a.36812","article-title":"Prader\u2013Willi syndrome can be diagnosed prenatally","volume":"167","author":"Gross","year":"2015","journal-title":"Am J Med Genet A"},{"issue":"1","key":"key2.024011506525e+13_B6","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/ajmg.a.36816","article-title":"Disease-specific growth charts for Korean infants with Prader\u2013Willi syndrome","volume":"167","author":"Lee","year":"2015","journal-title":"Am J Med Genet A"},{"issue":"11","key":"key2.024011506525e+13_B7","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1002\/ajmg.a.35581","article-title":"Development and implementation of electronic growth charts for infants with Prader\u2013Willi syndrome","volume":"158A","author":"Rosenbloom","year":"2012","journal-title":"Am J Med Genet A"},{"issue":"2","key":"key2.024011506525e+13_B8","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3390\/genes11020204","article-title":"Food and non-food-related behavior across settings in children with Prader\u2013Willi syndrome","volume":"11","author":"Gantz","year":"2020","journal-title":"Genes"},{"issue":"2","key":"key2.024011506525e+13_B9","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/ijo.2010.139","article-title":"Development of the eating behaviour in Prader\u2013Willi syndrome: advances in our understanding","volume":"35","author":"McAllister","year":"2011","journal-title":"Int J Obes"},{"issue":"10","key":"key2.024011506525e+13_B10","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1038\/ijo.2017.139","article-title":"Long-term health outcomes in patients with Prader\u2013Willi syndrome: a nationwide cohort study in Denmark","volume":"41","author":"Hedgeman","year":"2017","journal-title":"Int J Obes"},{"issue":"1","key":"key2.024011506525e+13_B11","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s13023-020-01440-6","article-title":"Three years of growth hormone treatment in young adults with Prader-Willi syndrome: sustained positive effects on body composition","volume":"15","author":"Damen","year":"2020","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"key2.024011506525e+13_B12","doi-asserted-by":"crossref","DOI":"10.1111\/obr.12992","article-title":"Current and emerging therapies for managing hyperphagia and obesity in Prader-Willi syndrome: a narrative review","volume":"21","author":"Tan","year":"2020","journal-title":"Obes Rev"},{"issue":"4","key":"key2.024011506525e+13_B13","doi-asserted-by":"crossref","first-page":"281","DOI":"10.6065\/apem.2142228.114","article-title":"Changes in lifestyle and obesity during the COVID-19 pandemic in Korean adolescents: based on the Korea Youth Risk Behavior Survey 2019 and 2020","volume":"27","author":"Kang","year":"2022","journal-title":"Ann Pediatr Endocrinol Metab"},{"issue":"1","key":"key2.024011506525e+13_B14","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/gim.2017.92","article-title":"Survival trends from the Prader\u2013Willi syndrome Association (USA) 40-year mortality survey","volume":"20","author":"Manzardo","year":"2018","journal-title":"Genet Med"},{"issue":"7","key":"key2.024011506525e+13_B15","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/ajmg.a.32133","article-title":"The Italian National Survey for Prader\u2013Willi syndrome: an epidemiologic study","volume":"146A","author":"Grugni","year":"2008","journal-title":"Am J Med Genet A"},{"issue":"6","key":"key2.024011506525e+13_B16","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/gim.2016.178","article-title":"Causes of death in Prader-Willi syndrome: Prader-Willi syndrome Association (USA) 40-year mortality survey","volume":"19","author":"Butler","year":"2017","journal-title":"Genet Med"},{"issue":"2","key":"key2.024011506525e+13_B17","doi-asserted-by":"crossref","first-page":"148","DOI":"10.6065\/apem.2142022.011","article-title":"Tailored management of life-threatening complications related to severe obesity in a young adult with Prader-Willi syndrome","volume":"27","author":"Kim","year":"2022","journal-title":"Ann Pediatr Endocrinol Metab"},{"issue":"4","key":"key2.024011506525e+13_B18","doi-asserted-by":"crossref","first-page":"289","DOI":"10.6065\/apem.2142230.115","article-title":"Cardiometabolic risk factors and metabolic syndrome based on severity of obesity in Korean children and adolescents: data from the Korea National Health and Nutrition Examination Survey 2007\u20132018","volume":"27","author":"Kim","year":"2022","journal-title":"Ann Pediatr Endocrinol Metab"},{"issue":"5","key":"key2.024011506525e+13_B19","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/jir.12140","article-title":"Medical, psychological and social features in a large cohort of adults with Prader\u2013Willi syndrome: experience from a dedicated centre in France","volume":"59","author":"Laurier","year":"2015","journal-title":"J Intellect Disabil Res"},{"issue":"4","key":"key2.024011506525e+13_B20","doi-asserted-by":"crossref","first-page":"273","DOI":"10.6065\/apem.2142226.113","article-title":"The association between C-reactive protein, metabolic syndrome, and prediabetes in Korean children and adolescents","volume":"27","author":"Kim","year":"2022","journal-title":"Ann Pediatr Endocrinol Metab"},{"issue":"(1-2)","key":"key2.024011506525e+13_B21","first-page":"23","article-title":"Effects of metformin in children and adolescents with Prader-Willi syndrome and early-onset morbid obesity: a pilot study","volume":"27","author":"Miller","year":"2014","journal-title":"J Pediatr Endocrinol Metab"},{"key":"key2.024011506525e+13_B22","doi-asserted-by":"crossref","DOI":"10.1007\/978-0-387-33536-0","volume-title":"Management of Prader-Willi syndrome","author":"Butler","year":"2006","edition":"3rd ed"},{"issue":"2","key":"key2.024011506525e+13_B23","doi-asserted-by":"crossref","first-page":"112","DOI":"10.6065\/apem.2040194.097","article-title":"A national survey of transition from pediatric to adult healthcare providers for adolescents and young adults with type 1 diabetes: perspectives of pediatric endocrinologists in Korea","volume":"26","author":"Kim","year":"2021","journal-title":"Ann Pediatr Endocrinol Metab"},{"issue":"6","key":"key2.024011506525e+13_B24","doi-asserted-by":"crossref","first-page":"E1072","DOI":"10.1210\/jc.2012-3888","article-title":"Growth Hormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome","volume":"98","author":"Deal","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"key2.024011506525e+13_B25","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ghir.2013.11.002","article-title":"Glucose homeostasis in adults with Prader\u2013Willi syndrome during treatment with growth hormone: results from a 12-month prospective study","volume":"24","author":"J\u00f8rgensen","year":"2014","journal-title":"Growth Horm IGF Res"},{"issue":"11","key":"key2.024011506525e+13_B26","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1111\/j.1651-2227.2010.01904.x","article-title":"Long-term effects of growth hormone therapy on patients with Prader\u2013Willi syndrome","volume":"99","author":"Sipil\u00e4","year":"2010","journal-title":"Acta Paediatr"},{"issue":"7","key":"key2.024011506525e+13_B27","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1515\/JPEM.2008.21.7.651","article-title":"Successful early dietary intervention avoids obesity in patients with Prader-Willi syndrome: a ten-year follow-up","volume":"21","author":"Schmidt","year":"2008","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"11","key":"key2.024011506525e+13_B28","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1210\/jc.2012-2543","article-title":"Approach to the child with Prader-Willi syndrome","volume":"97","author":"Miller","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"key2.024011506525e+13_B29","doi-asserted-by":"crossref","first-page":"905","DOI":"10.3945\/an.117.016253","article-title":"Energy metabolism profile in individuals with Prader-Willi syndrome and implications for clinical management: a systematic review","volume":"8","author":"Alsaif","year":"2017","journal-title":"Adv Nutr"},{"issue":"1","key":"key2.024011506525e+13_B30","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-277X.2012.01275.x","article-title":"A reduced-energy intake, well-balanced diet improves weight control in children with Prader-Willi syndrome","volume":"26","author":"Miller","year":"2013","journal-title":"J Hum Nutr Diet"},{"issue":"7","key":"key2.024011506525e+13_B31","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1136\/gutjnl-2019-320438","article-title":"Mediterranean diet intervention in overweight and obese subjects lowers plasma cholesterol and causes changes in the gut microbiome and metabolome independently of energy intake","volume":"69","author":"Meslier","year":"2020","journal-title":"Gut"},{"issue":"24","key":"key2.024011506525e+13_B32","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1080\/09638288.2019.1597176","article-title":"Physiotherapists perceived developing positive rapport facilitates participation in exercise among people with Prader-Willi syndrome: a qualitative study","volume":"42","author":"Shields","year":"2020","journal-title":"Disabil Rehabil"},{"issue":"3","key":"key2.024011506525e+13_B33","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/ajmg.a.37488","article-title":"Elevated plasma oxytocin levels in children with Prader\u2013Willi syndrome compared with healthy unrelated siblings","volume":"170","author":"Johnson","year":"2016","journal-title":"Am J Med Genet A"},{"key":"key2.024011506525e+13_B34","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pbb.2013.06.011","article-title":"Oxytocin, motivation and the role of dopamine","volume":"119","author":"Love","year":"2014","journal-title":"Pharmacol Biochem Behav"},{"issue":"2","key":"key2.024011506525e+13_B35","first-page":"573","article-title":"Alterations in the hypothalamic paraventricular nucleus and its oxytocin neurons (putative satiety cells) in Prader-Willi syndrome: a study of five cases","volume":"80","author":"Swaab","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"key2.024011506525e+13_B36","doi-asserted-by":"crossref","first-page":"102711","DOI":"10.1016\/j.dsx.2023.102711","article-title":"The efficacy of intranasal oxytocin in patients with Prader-Willi syndrome: a systematic review and meta-analysis","volume":"17","author":"Shalma","year":"2023","journal-title":"Diabetes Metab Syndr"},{"issue":"12","key":"key2.024011506525e+13_B37","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.98333","article-title":"Intranasal carbetocin reduces hyperphagia in individuals with Prader-Willi syndrome","volume":"3","author":"Dykens","year":"2018","journal-title":"JCI Insight"},{"issue":"7","key":"key2.024011506525e+13_B38","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1210\/clinem\/dgad015","article-title":"Intranasal carbetocin reduces hyperphagia, anxiousness, and distress in Prader-Willi syndrome: CARE-PWS phase 3 trial","volume":"108","author":"Roof","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"key2.024011506525e+13_B39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0221615","article-title":"A randomized pilot efficacy and safety trial of diazoxide choline controlled-release in patients with Prader-Willi syndrome","volume":"14","author":"Kimonis","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"key2.024011506525e+13_B40","doi-asserted-by":"crossref","first-page":"5","DOI":"10.5582\/irdr.2022.01127","article-title":"Hyperphagia in Prader-Willi syndrome with obesity: from development to pharmacological treatment","volume":"12","author":"Rahman","year":"2023","journal-title":"Intractable Rare Dis Res"},{"issue":"7","key":"key2.024011506525e+13_B41","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1210\/clinem\/dgad014","article-title":"Diazoxide choline extended-release tablet in people with Prader-Willi syndrome: a double-blind, placebo-controlled trial","volume":"108","author":"Miller","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"key2.024011506525e+13_B42","doi-asserted-by":"crossref","first-page":"T1","DOI":"10.1530\/JOE-13-0414","article-title":"Effects of glucagon-like peptide 1 on appetite and body weight: focus on the CNS","volume":"221","author":"van Bloemendaal","year":"2014","journal-title":"J Endocrinol"},{"issue":"8","key":"key2.024011506525e+13_B43","doi-asserted-by":"crossref","first-page":"E1314","DOI":"10.1210\/jc.2011-0038","article-title":"Effects of a single dose of exenatide on appetite, gut hormones, and glucose homeostasis in adults with Prader-Willi syndrome","volume":"96","author":"Sze","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"key2.024011506525e+13_B44","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1515\/jpem.2010.140","article-title":"Delayed gastric emptying in patients with Prader Willi syndrome","volume":"23","author":"Arenz","year":"2010","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"10","key":"key2.024011506525e+13_B45","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.molmet.2017.06.015","article-title":"Evaluation of a melanocortin-4 receptor (MC4R) agonist (setmelanotide) in MC4R deficiency","volume":"6","author":"Collet","year":"2017","journal-title":"Mol Metab"},{"issue":"3","key":"key2.024011506525e+13_B46","doi-asserted-by":"crossref","DOI":"10.1002\/mgg3.514","article-title":"A multidisciplinary approach to the clinical management of Prader\u2013Willi syndrome","volume":"7","author":"Duis","year":"2019","journal-title":"Mol Genet Genomic Med"},{"issue":"3","key":"key2.024011506525e+13_B47","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s40265-021-01470-9","article-title":"Setmelanotide: first approval","volume":"81","author":"Markham","year":"2021","journal-title":"Drugs"},{"issue":"1","key":"key2.024011506525e+13_B48","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13023-016-0440-0","article-title":"High unacylated ghrelin levels support the concept of anorexia in infants with Prader-Willi syndrome","volume":"11","author":"Beauloye","year":"2016","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"key2.024011506525e+13_B49","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s12020-015-0614-x","article-title":"Elevated ratio of acylated to unacylated ghrelin in children and young adults with Prader-Willi syndrome","volume":"50","author":"Kuppens","year":"2015","journal-title":"Endocrine"},{"key":"key2.024011506525e+13_B50","unstructured":"AdisInsight\nA phase 2b\/3 study to evaluate the safety, tolerability, and effects of livoletide (AZP-531), an unacylated ghrelin analogue, on food-related behaviors in patients with Prader-Willi syndrome [Internet]\nCham (CH)\nAdisInsight\nc2021\n[cited 2023 Sep 3]\nAvailable from: https:\/\/adisinsight.springer.com\/trials\/700299063"},{"issue":"5","key":"key2.024011506525e+13_B51","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/sj.bjp.0707133","article-title":"Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro","volume":"150","author":"Thomas","year":"2007","journal-title":"Br J Pharmacol"},{"key":"key2.024011506525e+13_B52","doi-asserted-by":"crossref","first-page":"102955","DOI":"10.1016\/j.autneu.2022.102955","article-title":"t-VNS to treat disorders of behaviour in Prader-Willi syndrome and in people with other neurodevelopmental conditions","volume":"239","author":"Holland","year":"2022","journal-title":"Auton Neurosci"},{"issue":"2","key":"key2.024011506525e+13_B53","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/ajmg.b.32401","article-title":"Transcranial direct current stimulation reduces food-craving and measures of hyperphagia behavior in participants with Prader-Willi syndrome","volume":"171","author":"Bravo","year":"2016","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"1","key":"key2.024011506525e+13_B54","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/YCT.0000000000000722","article-title":"Transcranial direct current stimulation for Prader-Willi syndrome","volume":"37","author":"Azevedo","year":"2021","journal-title":"J ECT"},{"issue":"2","key":"key2.024011506525e+13_B55","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3390\/brainsci11020250","article-title":"Effects of transcranial direct current stimulation (tDCS) on Go\/NoGo performance using food and non-food stimuli in patients with Prader-Willi syndrome","volume":"11","author":"Poje","year":"2021","journal-title":"Brain Sci"},{"issue":"1","key":"key2.024011506525e+13_B56","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/01.mpg.0000304458.30294.31","article-title":"Critical analysis of bariatric procedures in Prader-Willi syndrome","volume":"46","author":"Scheimann","year":"2008","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"4","key":"key2.024011506525e+13_B57","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1365-2265.2010.03840.x","article-title":"Thyroid axis dysfunction in patients with Prader-Willi syndrome during the first 2 years of life","volume":"73","author":"Vaiani","year":"2010","journal-title":"Clin Endocrinol"},{"issue":"1","key":"key2.024011506525e+13_B58","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/ajmg.a.36810","article-title":"Hyperghrelinemia in Prader-Willi syndrome begins in early infancy long before the onset of hyperphagia","volume":"167","author":"Kweh","year":"2015","journal-title":"Am J Med Genet A"},{"issue":"11","key":"key2.024011506525e+13_B59","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1210\/jc.2008-0649","article-title":"Recommendations for the diagnosis and management of Prader-Willi syndrome","volume":"93","author":"Goldstone","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"key2.024011506525e+13_B60","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1017\/S204017441400021X","article-title":"Leptin levels at birth and infant growth: the EPOCH study","volume":"5","author":"Kaar","year":"2014","journal-title":"J Dev Orig Health Dis"},{"issue":"1","key":"key2.024011506525e+13_B61","doi-asserted-by":"crossref","first-page":"E225","DOI":"10.1210\/jc.2010-1733","article-title":"The metabolic phenotype of Prader-Willi syndrome (PWS) in childhood: heightened insulin sensitivity relative to body mass index","volume":"96","author":"Haqq","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"key2.024011506525e+13_B62","doi-asserted-by":"crossref","first-page":"1297553","DOI":"10.1080\/16546628.2017.1297553","article-title":"Hedonic eating in Prader-Willi syndrome is associated with blunted PYY secretion","volume":"61","author":"Rigamonti","year":"2017","journal-title":"Food Nutr Res"},{"issue":"8","key":"key2.024011506525e+13_B63","doi-asserted-by":"crossref","first-page":"4228","DOI":"10.1002\/hbm.23660","article-title":"Brain structural alterations in obese children with and without Prader-Willi syndrome","volume":"38","author":"Xu","year":"2017","journal-title":"Hum Brain Mapp"},{"issue":"9","key":"key2.024011506525e+13_B64","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1002\/ajmg.a.37777","article-title":"Higher plasma orexin a levels in children with Prader\u2013Willi syndrome compared with healthy unrelated sibling controls","volume":"170","author":"Manzardo","year":"2016","journal-title":"Am J Med Genet A"},{"key":"key2.024011506525e+13_B65","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1750-1172-6-47","article-title":"Oxytocin may be useful to increase trust in others and decrease disruptive behaviours in patients with Prader-Willi syndrome: a randomised placebo-controlled trial in 24 patients","volume":"6","author":"Tauber","year":"2011","journal-title":"Orphanet J Rare Dis"},{"issue":"9","key":"key2.024011506525e+13_B66","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1002\/ajmg.a.36653","article-title":"A double-blind randomized controlled trial of oxytocin nasal spray in Prader Willi syndrome","volume":"164","author":"Einfeld","year":"2014","journal-title":"Am J Med Genet A"},{"issue":"6","key":"key2.024011506525e+13_B67","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/cen.13169","article-title":"Promising effects of oxytocin on social and food-related behaviour in young children with Prader\u2013Willi syndrome: a randomized, double-blind, controlled crossover trial","volume":"85","author":"Kuppens","year":"2016","journal-title":"Clin Endocrinol"},{"issue":"5","key":"key2.024011506525e+13_B68","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/ajmg.a.38160","article-title":"Oxytocin treatment in children with Prader\u2013Willi syndrome: a double-blind, placebo-controlled, crossover study","volume":"173","author":"Miller","year":"2017","journal-title":"Am J Med Genet A"},{"issue":"2","key":"key2.024011506525e+13_B69","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-2976","article-title":"The use of oxytocin to improve feeding and social skills in infants with Prader-Willi syndrome","volume":"139","author":"Tauber","year":"2017","journal-title":"Pediatrics"},{"issue":"5","key":"key2.024011506525e+13_B70","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/cen.14387","article-title":"Oxytocin in young children with Prader-Willi syndrome: results of a randomized, double-blind, placebo-controlled, crossover trial investigating 3 months of oxytocin","volume":"94","author":"Damen","year":"2021","journal-title":"Clin Endocrinol"},{"key":"key2.024011506525e+13_B71","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.jpsychires.2020.11.006","article-title":"Intranasal oxytocin versus placebo for hyperphagia and repetitive behaviors in children with Prader-Willi syndrome: a randomized controlled pilot trial","volume":"137","author":"Hollander","year":"2021","journal-title":"J Psychiatr Res"},{"issue":"3","key":"key2.024011506525e+13_B72","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1136\/jmedgenet-2018-105301","article-title":"Molecular genetic classification in Prader-Willi syndrome: a multisite cohort study","volume":"56","author":"Butler","year":"2019","journal-title":"J Med Genet"},{"issue":"12","key":"key2.024011506525e+13_B73","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1111\/dom.13021","article-title":"Effects of MetAP2 inhibition on hyperphagia and body weight in Prader\u2013Willi syndrome: a randomized, double-blind, placebo-controlled trial","volume":"19","author":"McCandless","year":"2017","journal-title":"Diabetes Obes Metab"}],"container-title":["The Ewha Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.e-emj.org\/download\/download_pdf?doi=10.12771\/emj.2023.e32","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.e-emj.org\/download\/download_pdf?doi=10.12771\/emj.2023.e32","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T02:08:02Z","timestamp":1741226882000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-emj.org\/journal\/view.php?doi=10.12771\/emj.2023.e32"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,31]]},"references-count":73,"journal-issue":{"issue":"s1","published-online":{"date-parts":[[2023,12,31]]}},"alternative-id":["10.12771\/emj.2023.e32"],"URL":"https:\/\/doi.org\/10.12771\/emj.2023.e32","relation":{},"ISSN":["2234-2591"],"issn-type":[{"type":"electronic","value":"2234-2591"}],"subject":[],"published":{"date-parts":[[2023,12,31]]},"assertion":[{"value":"2023-10-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-17","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e32"}}